Evidence map›Paper›PMID 26739563›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Novel cystine transporter in renal proximal tubule identified as a missing partner of cystinuria-related plasma membrane protein rBAT/SLC3A1.

Shushi Nagamori, Pattama Wiriyasermkul, Meritxell Espino Guarch, Hirohisa Okuyama, Saya Nakagomi, Kenjiro Tadagaki, Yumiko Nishinaka, Susanna Bodoy, Kazuaki Takafuji, Suguru Okuda and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. ATF4 in proximal tubules modulates kidney function and modifies the metabolome.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Shushi NagamoriDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Pattama WiriyasermkulDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Meritxell Espino GuarchInstitute for Research in Biomedicine Barcelona, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Molecular Genetics Laboratory, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain; Spanish Biomedical Research Center in Rare Diseases (CIBERER), 08028 Barcelona, Spain;
Hirohisa OkuyamaDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Saya NakagomiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Kenjiro TadagakiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Yumiko NishinakaDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Susanna BodoyInstitute for Research in Biomedicine Barcelona, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Spanish Biomedical Research Center in Rare Diseases (CIBERER), 08028 Barcelona, Spain;
Kazuaki TakafujiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Suguru OkudaDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Junko KurokawaDepartment of Bio-Informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan;
Ryuichi OhgakiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan;
Virginia NunesMolecular Genetics Laboratory, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain; Spanish Biomedical Research Center in Rare Diseases (CIBERER), 08028 Barcelona, Spain; Genetic Unit, Department of Physiological Sciences II, Universitat de Barcelona, 08908 Barcelona, Spain;
Manuel PalacínInstitute for Research in Biomedicine Barcelona, The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain; Spanish Biomedical Research Center in Rare Diseases (CIBERER), 08028 Barcelona, Spain; Department of Biochemistry and Molecular Biology, Facultat de Biologia, University of Barcelona, 08028 Barcelona, Spain.
Yoshikatsu KanaiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan; ykanai@pharma1.med.osaka-u.ac.jp.
Osaka University · JPInstitut d'Investigació Biomédica de Bellvitge · ESCentre for Biomedical Network Research on Rare Diseases · ESInstitute for Research in Biomedicine · ESTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterodimeric amino acid transporters play crucial roles in epithelial transport, as well as in cellular nutrition. Among them, the heterodimer of a membrane protein b(0,+)AT/SLC7A9 and its auxiliary subunit rBAT/SLC3A1 is responsible for cystine reabsorption in renal proximal tubules. The mutations in either subunit cause cystinuria, an inherited amino aciduria with impaired renal reabsorption of cystine and dibasic amino acids. However, an unsolved paradox is that rBAT is highly expressed in the S3 segment, the late proximal tubules, whereas b(0,+)AT expression is highest in the S1 segment, the early proximal tubules, so that the presence of an unknown partner of rBAT in the S3 segment has been proposed. In this study, by means of coimmunoprecipitation followed by mass spectrometry, we have found that a membrane protein AGT1/SLC7A13 is the second partner of rBAT. AGT1 is localized in the apical membrane of the S3 segment, where it forms a heterodimer with rBAT. Depletion of rBAT in mice eliminates the expression of AGT1 in the renal apical membrane. We have reconstituted the purified AGT1-rBAT heterodimer into proteoliposomes and showed that AGT1 transports cystine, aspartate, and glutamate. In the apical membrane of the S3 segment, AGT1 is suggested to locate itself in close proximity to sodium-dependent acidic amino acid transporter EAAC1 for efficient functional coupling. EAAC1 is proposed to take up aspartate and glutamate released into luminal fluid by AGT1 due to its countertransport so that preventing the urinary loss of aspartate and glutamate. Taken all together, AGT1 is the long-postulated second cystine transporter in the S3 segment of proximal tubules and a possible candidate to be involved in isolated cystinuria.

Indexed as

Amino Acid SequenceAmino Acid Transport SystemsAmino Acid Transport Systems, BasicAmino Acid Transport Systems, NeutralAnimalsAntibodiesBlotting, WesternCell MembraneCystinuriaExcitatory Amino Acid Transporter 3FemaleHEK293 CellsHumansImmunohistochemistryIn Situ HybridizationKidneyAmino Acid Transport SystemsAmino Acid Transport Systems, BasicAmino Acid Transport Systems, NeutralAntibodiesExcitatory Amino Acid Transporter 3ProteolipidsproteoliposomesRNA, MessengerSlc1a1 protein, mouseSlc3a1 protein, mouseSlc7a13 protein, mouseamino acid transportercystine reabsorptioncystinuriakidney

Identifiers

PMID26739563
PMCPMC4725474
OpenAlexW2225856091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.